Evidence for parasympathetic vasodilator fibres in the rat masseter muscle.
The present study was designed to examine (1) whether there are vasodilator fibres in the masseter muscle, and (2) if there are, to establish the neural pathways mediating these responses in urethane-anaesthetized rats. Electrical stimulation of the central cut end of the lingual nerve (LN) elicited intensity- and frequency-dependent increases of the blood flow in the masseter muscle (MBF) and lower lip (LBF). Increases in both the MBF and LBF evoked by the LN stimulation were reduced by hexamethonium in a dose-dependent manner (1-10 mg kg(-1)). Pretreatment with phentolamine or propranolol at a dose of 100 microg kg(-1) had no effect on the increases in either MBF or LBF evoked by LN stimulation. Pretreatment with atropine (100 microg kg(-1)) significantly reduced the MBF increase induced by LN stimulation, but not that in the LBF. The sectioning of the superior cervical sympathetic trunk did not affect the responses. MBF increases occurred with electrical stimulation of the trigeminal ganglion, and these increases were significantly reduced by the administration of hexamethonium and atropine. Lidocaine microinjection into the trigeminal spinal nucleus or salivatory nuclei caused a significant attenuation of the LN-induced MBF increases. When wheat germ agglutinin-horseradish peroxidase (WGA-HRP) was injected into the masseter muscle, labelled neurones were abundantly observed in the otic ganglion. The present study indicates that there are parasympathetic cholinergic and noncholinergic vasodilator fibres originating from cell bodies in the otic ganglion in the rat masseter muscle. The MBF increase evoked by activation of the parasympathetic fibres occurred via the trigeminal mediated reflex, suggesting that the novel parasympathetic vasodilator response may play an important role in the regulation of the haemodynamics of jaw muscles.
Ishii
Hisayoshi
H
Department of Oral Physiology, Health Sciences University of Hokkaido, 1757 Kanazawa, Ishikari-Tobetsu, Hokkaido 061-0293, Japan.
Niioka
Takeharu
T
Sudo
Emi
E
Izumi
Hiroshi
H
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000502:physiology; D004558:Electric Stimulation; D005726:Ganglia, Parasympathetic / Q000166:cytology / Q000502:physiology*; D006439:Hemodynamics / Q000502:physiology; D018738:Hexamethonium / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology; D008036:Lingual Nerve / Q000502:physiology; D008297:Male; D008406:Masseter Muscle / Q000098:blood supply / Q000294:innervation* / Q000502:physiology*; D009412:Nerve Fibers / Q000502:physiology*; D010276:Parasympatholytics / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012039:Regional Blood Flow / Q000502:physiology; D012668:Trigeminal Ganglion / Q000502:physiology; D014664:Vasodilation / Q000502:physiology*
D010276:Parasympatholytics; D018738:Hexamethonium; D001285:Atropine; D008012:Lidocaine; D010646:Phentolamine